AGR2 and cancer: This was an important finding of our work in the context of the suggested role of PDIA17 in genomic integrity, proliferation, apoptosis, angiogenesis, adhesion, migration, stemness and inflammation [18, 36], indicating that PDIA17 is a promising target for anti-cancer treatment.